Immunic, Inc. (IMUX) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Win.
21/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinIMUX / S&P 38.47% / 15.20% |
LoseIMUX / S&P IMUX unavailable / 15.00% |
LoseIMUX / S&P -58.65% / 50.40% |
| 2026-Q11/3 |
WinIMUX / S&P 107.87% / -4.33% |
LoseIMUX / S&P IMUX unavailable / 11.30% |
LoseIMUX / S&P 3.12% / 27.70% |
| 2025-Q41/3 |
LoseIMUX / S&P -39.46% / 2.65% |
LoseIMUX / S&P IMUX unavailable / 9.00% |
WinIMUX / S&P 374.00% / 13.40% |
| 2025-Q32/3 |
WinIMUX / S&P 26.36% / 8.12% |
LoseIMUX / S&P IMUX unavailable / 4.61% |
WinIMUX / S&P 300.00% / 13.45% |
| 2025-Q21/3 |
LoseIMUX / S&P -35.96% / 10.94% |
LoseIMUX / S&P IMUX unavailable / 4.83% |
WinIMUX / S&P 235.33% / 10.63% |
| 2025-Q12/3 |
WinIMUX / S&P 9.00% / -4.27% |
LoseIMUX / S&P IMUX unavailable / 4.98% |
WinIMUX / S&P 75.41% / 10.57% |
| 2024-Q40/3 |
LoseIMUX / S&P -39.39% / 2.41% |
LoseIMUX / S&P IMUX unavailable / 5.25% |
LoseIMUX / S&P -52.61% / 6.15% |
| 2024-Q31/3 |
WinIMUX / S&P 48.65% / 5.89% |
LoseIMUX / S&P IMUX unavailable / 5.89% |
LoseIMUX / S&P -62.15% / 6.11% |
| 2024-Q20/3 |
LoseIMUX / S&P -15.91% / 4.28% |
LoseIMUX / S&P IMUX unavailable / 5.38% |
LoseIMUX / S&P -56.27% / 5.12% |
| 2024-Q10/3 |
LoseIMUX / S&P -12.00% / 10.56% |
LoseIMUX / S&P IMUX unavailable / 5.71% |
LoseIMUX / S&P -49.31% / 5.59% |
| 2023-Q40/3 |
LoseIMUX / S&P 2.04% / 11.69% |
LoseIMUX / S&P IMUX unavailable / 6.81% |
LoseIMUX / S&P -44.03% / 7.78% |
| 2023-Q31/3 |
LoseIMUX / S&P -41.43% / -3.27% |
LoseIMUX / S&P IMUX unavailable / 7.52% |
WinIMUX / S&P 18.18% / -5.03% |
| 2023-Q22/3 |
WinIMUX / S&P 68.46% / 8.74% |
LoseIMUX / S&P IMUX unavailable / 9.50% |
WinIMUX / S&P 21.63% / -8.57% |
| 2023-Q11/3 |
LoseIMUX / S&P 6.43% / 7.50% |
LoseIMUX / S&P IMUX unavailable / 10.77% |
WinIMUX / S&P 23.63% / -15.69% |
| 2022-Q41/3 |
LoseIMUX / S&P -55.70% / 7.56% |
LoseIMUX / S&P IMUX unavailable / 11.88% |
WinIMUX / S&P -1.05% / -17.99% |
| 2022-Q30/3 |
LoseIMUX / S&P -8.93% / -4.88% |
LoseIMUX / S&P IMUX unavailable / 13.47% |
LoseIMUX / S&P IMUX unavailable / -1.41% |
| 2022-Q20/3 |
LoseIMUX / S&P -69.29% / -16.10% |
LoseIMUX / S&P IMUX unavailable / 13.71% |
LoseIMUX / S&P IMUX unavailable / 11.04% |
| 2022-Q11/3 |
WinIMUX / S&P 18.08% / -4.60% |
LoseIMUX / S&P IMUX unavailable / 15.97% |
LoseIMUX / S&P IMUX unavailable / 42.23% |
| 2021-Q40/3 |
LoseIMUX / S&P 8.14% / 11.03% |
LoseIMUX / S&P IMUX unavailable / 15.00% |
LoseIMUX / S&P IMUX unavailable / 96.40% |
| 2021-Q30/3 |
LoseIMUX / S&P -27.81% / 0.58% |
LoseIMUX / S&P IMUX unavailable / 10.77% |
LoseIMUX / S&P IMUX unavailable / 69.42% |
| 2021-Q20/3 |
LoseIMUX / S&P -23.09% / 8.55% |
LoseIMUX / S&P IMUX unavailable / 6.58% |
LoseIMUX / S&P IMUX unavailable / 51.81% |
| 2021-Q10/3 |
LoseIMUX / S&P 4.25% / 6.17% |
LoseIMUX / S&P IMUX unavailable / -1.06% |
LoseIMUX / S&P IMUX unavailable / 7.39% |
| 2020-Q40/3 |
LoseIMUX / S&P -17.66% / 12.15% |
LoseIMUX / S&P IMUX unavailable / -3.72% |
LoseIMUX / S&P IMUX unavailable / -33.42% |
| 2020-Q31/3 |
WinIMUX / S&P 53.22% / 8.93% |
LoseIMUX / S&P IMUX unavailable / -2.04% |
LoseIMUX / S&P IMUX unavailable / -27.10% |
| 2020-Q21/3 |
WinIMUX / S&P 100.33% / 20.54% |
LoseIMUX / S&P IMUX unavailable / -0.46% |
LoseIMUX / S&P IMUX unavailable / -27.11% |
| 2020-Q10/3 |
LoseIMUX / S&P -37.63% / -19.60% |
LoseIMUX / S&P IMUX unavailable / 3.47% |
LoseIMUX / S&P IMUX unavailable / -14.75% |
| 2019-Q40/3 |
LoseIMUX / S&P -3.00% / 9.07% |
LoseIMUX / S&P IMUX unavailable / 5.36% |
LoseIMUX / S&P IMUX unavailable / 2.99% |
| 2019-Q30/3 |
LoseIMUX / S&P -12.82% / 1.70% |
LoseIMUX / S&P IMUX unavailable / 5.02% |
LoseIMUX / S&P IMUX unavailable / 0.21% |
| 2019-Q21/3 |
WinIMUX / S&P 45.56% / 4.30% |
LoseIMUX / S&P IMUX unavailable / 6.64% |
LoseIMUX / S&P IMUX unavailable / 8.65% |
| 2019-Q10/3 |
LoseIMUX / S&P 5.91% / 13.65% |
LoseIMUX / S&P IMUX unavailable / 8.12% |
LoseIMUX / S&P IMUX unavailable / 14.29% |
| 2018-Q40/3 |
LoseIMUX / S&P -32.36% / -13.52% |
LoseIMUX / S&P IMUX unavailable / 9.05% |
LoseIMUX / S&P IMUX unavailable / 18.23% |
| 2018-Q30/3 |
LoseIMUX / S&P -95.99% / 7.71% |
LoseIMUX / S&P IMUX unavailable / 10.21% |
LoseIMUX / S&P IMUX unavailable / 19.06% |
| 2018-Q20/3 |
LoseIMUX / S&P 0.74% / 3.43% |
LoseIMUX / S&P IMUX unavailable / 9.03% |
LoseIMUX / S&P IMUX unavailable / 14.46% |
| 2018-Q11/3 |
WinIMUX / S&P 14.29% / -0.76% |
LoseIMUX / S&P IMUX unavailable / 7.68% |
LoseIMUX / S&P IMUX unavailable / 12.46% |
| 2017-Q41/3 |
WinIMUX / S&P 17.82% / 6.64% |
LoseIMUX / S&P IMUX unavailable / 7.03% |
LoseIMUX / S&P IMUX unavailable / 13.82% |
| 2017-Q31/3 |
WinIMUX / S&P 74.14% / 4.48% |
LoseIMUX / S&P IMUX unavailable / 5.68% |
LoseIMUX / S&P IMUX unavailable / 17.57% |
| 2017-Q20/3 |
LoseIMUX / S&P -27.50% / 3.09% |
LoseIMUX / S&P IMUX unavailable / 4.83% |
LoseIMUX / S&P IMUX unavailable / 17.74% |
| 2017-Q10/3 |
LoseIMUX / S&P -8.05% / 6.07% |
LoseIMUX / S&P IMUX unavailable / 3.67% |
LoseIMUX / S&P IMUX unavailable / 13.32% |
| 2016-Q40/3 |
LoseIMUX / S&P -28.92% / 3.82% |
LoseIMUX / S&P IMUX unavailable / 2.09% |
LoseIMUX / S&P IMUX unavailable / 7.05% |
| 2016-Q30/3 |
LoseIMUX / S&P -1.29% / 3.85% |
LoseIMUX / S&P IMUX unavailable / 0.20% |
LoseIMUX / S&P IMUX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | IMUX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 98.78% | 20.78% |
| Annualized return | 98.78% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | IMUX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -83.59% | 83.14% |
| Annualized return | -30.33% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | IMUX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.31% | 319.30% |
| Annualized return | -39.18% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |